69819-86-9,MFCD17215931
Catalog No.:AA00FGIJ

69819-86-9 | Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥95%
in stock  
$46.00   $32.00
- +
5mg
≥95%
in stock  
$188.00   $131.00
- +
10mg
in stock  
$283.00   $198.00
- +
25mg
in stock  
$528.00   $370.00
- +
50mg
in stock  
$854.00   $598.00
- +
100mg
in stock  
$1,431.00   $1,002.00
- +
500mg
in stock  
$4,477.00   $3,134.00
- +
1000mg
in stock  
$7,126.00   $4,988.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00FGIJ
Chemical Name:
Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-
CAS Number:
69819-86-9
Molecular Formula:
C12H22AsN3O6S
Molecular Weight:
411.3062
MDL Number:
MFCD17215931
SMILES:
C[As](SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C
Properties
Computed Properties
 
Complexity:
449  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
5  
Rotatable Bond Count:
11  

Literature

Title: The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20141201

Title: The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.

Journal: Leukemia 20131101

Title: Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20120615

Title: A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.

Journal: American journal of hematology 20120101

Title: Darinaparsin is a multivalent chemotherapeutic which induces incomplete stress response with disruption of microtubules and Shh signaling.

Journal: PloS one 20110101

Title: Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.

Journal: Investigational new drugs 20101001

Title: Darinaparsin: a novel organic arsenical with promising anticancer activity.

Journal: Expert opinion on investigational drugs 20091101

Title: Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Journal: Clinical rheumatology 20090801

Title: A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20090715

Title: Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.

Journal: Molecular cancer therapeutics 20090501

Title: Chemical and clinical development of darinaparsin, a novel organic arsenic derivative.

Journal: Anti-cancer agents in medicinal chemistry 20081201

Title: A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.

Journal: Leukemia 20081001

Title: Development of mass spectrometric methods for detecting arsenic-glutathione complexes.

Journal: Journal of the American Society for Mass Spectrometry 20081001

Title: Pentavalent arsenic can bind to biomolecules.

Journal: Angewandte Chemie (International ed. in English) 20070101

Title: Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).

Journal: British journal of pharmacology 20061201

Title: Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals.

Journal: Toxicology 20061003

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 69819-86-9
Tags:69819-86-9 Molecular Formula|69819-86-9 MDL|69819-86-9 SMILES|69819-86-9 Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-
Catalog No.: AA00FGIJ
69819-86-9,MFCD17215931
69819-86-9 | Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-
Pack Size: 1mg
Purity: ≥95%
in stock
$46.00 $32.00
Pack Size: 5mg
Purity: ≥95%
in stock
$188.00 $131.00
Pack Size: 10mg
Purity:
in stock
$283.00 $198.00
Pack Size: 25mg
Purity:
in stock
$528.00 $370.00
Pack Size: 50mg
Purity:
in stock
$854.00 $598.00
Pack Size: 100mg
Purity:
in stock
$1,431.00 $1,002.00
Pack Size: 500mg
Purity:
in stock
$4,477.00 $3,134.00
Pack Size: 1000mg
Purity:
in stock
$7,126.00 $4,988.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00FGIJ
Chemical Name: Glycine, L-γ-glutaMyl-S-(diMethylarsino)-L-cysteinyl-
CAS Number: 69819-86-9
Molecular Formula: C12H22AsN3O6S
Molecular Weight: 411.3062
MDL Number: MFCD17215931
SMILES: C[As](SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C
Properties
Complexity: 449  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Heavy Atom Count: 23  
Hydrogen Bond Acceptor Count: 8  
Hydrogen Bond Donor Count: 5  
Rotatable Bond Count: 11  
Literature fold

Title: The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20141201

Title: The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.

Journal: Leukemia20131101

Title: Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20120615

Title: A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.

Journal: American journal of hematology20120101

Title: Darinaparsin is a multivalent chemotherapeutic which induces incomplete stress response with disruption of microtubules and Shh signaling.

Journal: PloS one20110101

Title: Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.

Journal: Investigational new drugs20101001

Title: Darinaparsin: a novel organic arsenical with promising anticancer activity.

Journal: Expert opinion on investigational drugs20091101

Title: Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Journal: Clinical rheumatology20090801

Title: A phase I clinical trial of darinaparsin in patients with refractory solid tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20090715

Title: Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.

Journal: Molecular cancer therapeutics20090501

Title: Chemical and clinical development of darinaparsin, a novel organic arsenic derivative.

Journal: Anti-cancer agents in medicinal chemistry20081201

Title: A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.

Journal: Leukemia20081001

Title: Development of mass spectrometric methods for detecting arsenic-glutathione complexes.

Journal: Journal of the American Society for Mass Spectrometry20081001

Title: Pentavalent arsenic can bind to biomolecules.

Journal: Angewandte Chemie (International ed. in English)20070101

Title: Toxicity of a trivalent organic arsenic compound, dimethylarsinous glutathione in a rat liver cell line (TRL 1215).

Journal: British journal of pharmacology20061201

Title: Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals.

Journal: Toxicology20061003

Building Blocks More >
664364-29-8
664364-29-8
Ethyl 1-boc-3-pyrrolidine acetate
AA00FGTU | MFCD11977331
67858-48-4
67858-48-4
1H-Pyrrole-2,4-dicarboxylic acid 2-Methyl ester
AA00FH12 | MFCD13183827
68449-31-0
68449-31-0
4-(2-chloro-phenyl)-butyric acid
AA00FHEE | MFCD00624878
719277-30-2
719277-30-2
ProINDY
AA00FHR5 | MFCD27937773
67997-54-0
67997-54-0
Benzenemethanol, -alpha--(1-aminocyclopropyl)-
AA00FJF9 | MFCD20710967
66410-36-4
66410-36-4
7-(Chlorosulfonyl)-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid
AA00FM0O | MFCD09042610
72228-39-8
72228-39-8
1H-Indole-3-aceticacid,-alpha-,1-dimethyl-(9CI)
AA00FRRR | MFCD09751724
6579-44-8
6579-44-8
N-(2,3-DIMETHYL-PHENYL)-2-HYDROXYIMINO-ACETAMIDE
AA00FU0U | MFCD04610449
66234-79-5
66234-79-5
[1,2,4]Triazolo[1,5-a]pyrimidine-2-thiol
AA00FX89 | MFCD08444303
69318-23-6
69318-23-6
Phenol, 2-fluoro-6-(2-propenyl)- (9CI)
AA00G0XJ | MFCD16742696
Submit
© 2017 AA BLOCKS, INC. All rights reserved.